Attackers are increasingly exploiting generative AI by embedding malicious prompts in macros and exposing hidden data through parsers. The switch in adversarial tactics — noted in a recent State of ...

An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Rules for injection wells are on the books in Upper Burrell. Supervisors on Wednesday approved regulations for injection wells that would allow them as a conditional use in industrial-zoned areas in ...

Leqembi (lecanemab-irmb) is a prescription medicine approved to treat early stages of Alzheimer's disease, such as mild cognitive impairment or mild dementia. The recent FDA approval of Leqembi IQLIK ...

The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...

Please provide your email address to receive an email when new articles are posted on . Leqembi Iqlik is the first approved in-home anti-amyloid injectable for early Alzheimer’s disease. Patients ...

Micah Parsons' back issue might be something after all. While some viewed his "back tightness" designation at Dallas Cowboys camp as a way to mask the fact he didn’t have his desired long-term ...

As Micah Parsons gets his start with the Green Bay Packers, his first appearance with the team might be up in the air. Parsons has been dealing with a L4/L5 facet joint sprain in the vertebrae in his ...

Block Energy plc said it has completed the initial injection of carbon dioxide (CO2) of its carbon capture and storage (CCS) project in the Eastern European region of Georgia. No CO2 leakage on the ...

AI agents that can control and read data from an internet browser are also susceptible to obeying malicious text circulating in web content. When he's not battling bugs and robots in Helldivers 2, ...

Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...